Shashank Joshi - Researcher Profile | RDL Research Database

Publications

4 shown

Urban rural differences in prevalence of self-reported diabetes in India—The WHO–ICMR Indian NCD risk factor surveillance

Viswanathan Mohan , Prashant Mathur , R Deepa +9 more

2008 Diabetes Research and Clinical Practice 303 citations

Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.

M Prashanth , H K Ganesh , M V Vima +9 more

Prevalence of NAFLD and NASH in our cohort of type 2 DM patients is high and increases with multiple components of metabolic syndrome. NASH and advanced fibrosis can occur in di...

2009 PubMed 219 citations

Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India

Awadhesh Kumar Singh , Ritu Singh , Shashank Joshi +1 more

2021 Diabetes & Metabolic Syndrome Clinica... 1072 citations

Effectiveness and safety of saroglitazar in managing dyslipidaemia and liver enzymes in patients with type 2 diabetes, <scp>MASLD</scp> , and Stage 3 chronic kidney disease: A 12‐month observational study

Gaurab Bhaduri , Shambo Samrat Samajdar , Sanjay Bandyopadhyay +2 more

2025 Diabetes Obesity and Metabolism 0 citations

Frequent Co-Authors

Gaurab Bhaduri

Shambo Samrat Samajdar

KPC Medical College and Hospital

Sanjay Bandyopadhyay

Researcher Info

h-index: 3
Publications: 4
Citations: 1,594
Institution: Government Medical College

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-0990-5821

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.